AdaljaAA, WarmbrodKL, LancasterMJ. Introduction to the special feature: threat agnostic approaches to biodefence and public health are now a reality. Health Secur. 2024; 22(1):1-2.
2.
National Academies of Sciences, Engineering, and Medicine. Biodefense in the Age of Synthetic Biology. Washington, DC: The National Academies Press; 2018. Accessed March28, 2024. https://doi.org/10.17226/24890
3.
DownieDL, RaoP, David-FerdonC, et al.Literature review of pathogen agnostic molecular testing of clinical specimens from difficult-to-diagnose patients: implications for public health. Health Secur. 2024; 22(2):93-107.
4.
DownieDL, RaoP, David-FerdonC, et al.Surveillance for emerging and reemerging pathogens using pathogen agnostic metagenomic sequencing in the United States: a critical role for federal government agencies. Health Secur. 2024; 22(2):85-92.
5.
RubinE, HarveyC, VillatoroA, DeanB. Next generation public health emergency readiness: standardized tools and a threat agnostic biosurveillance system. Health Secur. 2024; 22(2):140-145.
6.
LimY-B, PopescuS. Exploring list-based approaches and potential threat agnostic applications in US biodefense and public health—toward a hybrid approach. Health Secur. 2024; 22(2):146-155.
7.
SrikrishnaD. Pentagon found daily, metagenomic detection of novel bioaerosol threats to be cost-prohibitive: can virtualization and AI make it cost-effective?. Health Secur. 2024; 22(2):108-129.
8.
EisenkraftA. Threat agnostic approach to epidemic management using continuous remote patient monitoring. Health Secur. 2024; 22(2):156-158.
9.
LinA, TorresCM, HobbsEC, et al.Computational and systems biology advances to enable bioagent agnostic signatures. Health Secur. 2024; 22(2):130-139.
